|
Summary Information: Renovacor Inc. Common Stock AMEX:RCOR |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Renovacor is a preclinical stage gene therapy company developing a pipeline of innovative and proprietary AAV-based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor’s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
__The following are links to various summary and news pages for __Renovacor Inc. Common Stock [ RCOR ]. __Note: Some Links might not have information for the company. |
|